SellerX Seventeen GmbH – Trademark Portfolio

Entity Type: 99

SellerX Seventeen GmbH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CYNPEL. The owner is based in BERLIN.

Chausseestr. 19

BERLIN 10115 , DE

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CYNPEL
CYNPEL
Registered 2022
CYNPEL
CYNPEL
Registered 2019

Trademark Classifications

SellerX Seventeen GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SellerX Seventeen GmbH have?

SellerX Seventeen GmbH has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does SellerX Seventeen GmbH file in?

SellerX Seventeen GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are SellerX Seventeen GmbH's most well-known trademarks?

SellerX Seventeen GmbH's registered trademark portfolio includes well-known marks such as CYNPEL. These are among 2 currently registered trademarks in the portfolio.

What is SellerX Seventeen GmbH's trademark registration success rate?

SellerX Seventeen GmbH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.